The Record - for physicians and other health care providers to share with their office staffs Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article
April 2016

Policy update: Percutaneous left atrial appendage closure device

Blue Cross Blue Shield of Michigan and Blue Care Network have updated the medical policy regarding the use of an Food and Drug Administration-approved percutaneous left atrial appendage closure device (e.g., the Watchman™).

The safety and effectiveness of this device for stroke prevention in patients with atrial fibrillation has been established. The policy was effective Jan. 1, 2016.

This procedure (CPT code *0281T) may be performed in the inpatient or outpatient facility setting. The performing physician determines the most appropriate setting, depending on factors such as co-morbidities or the risk of complications.

To read the full medical policy, click here.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2015 American Medical Association. All rights reserved.
Blue Cross Blue Shield of Michigan and Blue Care Network are nonprofit corporations and
independent licensees of the Blue Cross and Blue Shield Association.